Revenue Breakdown
Composition ()
No data
Revenue Streams
Bruker Corp (BRKR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product, accounting for 80.3% of total sales, equivalent to $691.10M. Other significant revenue streams include Product And Service Other and Service and other revenue. Understanding this composition is critical for investors evaluating how BRKR navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Bruker Corp maintains a gross margin of 46.44%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.60%, while the net margin is -6.80%. These profitability ratios, combined with a Return on Equity (ROE) of -1.12%, provide a clear picture of how effectively BRKR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BRKR competes directly with industry leaders such as MASI and BIO. With a market capitalization of $7.39B, it holds a significant position in the sector. When comparing efficiency, BRKR's gross margin of 46.44% stands against MASI's 62.07% and BIO's 52.50%. Such benchmarking helps identify whether Bruker Corp is trading at a premium or discount relative to its financial performance.
